Q4 2023 Holdings
Filed 2024-02-15 | 425 holdings | $157.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| OFS Cap Corp(OFS) | COM | 67103B100 | $296.6K | 25,347 | 0.2% |
| Invesco Quality MUN Income T(IQI) | COM | 46133G107 | $303.1K | 31,868 | 0.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $303.9K | 50,731 | 0.2% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $305.6K | 8,269 | 0.2% |
| Gladstone Invt Corp(GAIN) | COM | 376546107 | $311.3K | 21,997 | 0.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $311.9K | 9,657 | 0.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $312.6K | 14,036 | 0.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $313.6K | 1,739 | 0.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $319.7K | 5,314 | 0.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $320.9K | 5,110 | 0.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $322.2K | 3,342 | 0.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $323.1K | 3,989 | 0.2% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $324.5K | 5,183 | 0.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $324.8K | 36,124 | 0.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $325.7K | 11,819 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $325.8K | 22,130 | 0.2% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $325.9K | 28,489 | 0.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $329.1K | 29,308 | 0.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $329.2K | 1,272 | 0.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $331.2K | 3,138 | 0.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $331.3K | 6,548 | 0.2% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $332.4K | 20,606 | 0.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $332.8K | 3,451 | 0.2% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $333.0K | 29,628 | 0.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $333.3K | 15,380 | 0.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $334.8K | 1,749 | 0.2% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $335.6K | 19,132 | 0.2% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $335.7K | 13,994 | 0.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $339.8K | 7,105 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $339.8K | 37,798 | 0.2% |
| Amgen Inc(AMGN) | COM | 031162100 | $340.2K | 1,181 | 0.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $342.1K | 2,716 | 0.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $343.3K | 9,406 | 0.2% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $344.1K | 4,818 | 0.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $345.5K | 17,061 | 0.2% |
| BNY Mellon Alcentra Global C(XDCFX) | COM | 05588N108 | $347.8K | 42,673 | 0.2% |
| Main STR Cap Corp(MAIN) | COM | 56035L104 | $348.2K | 8,054 | 0.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $348.7K | 5,104 | 0.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $349.2K | 7,597 | 0.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $350.0K | 11,295 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $354.2K | 2,688 | 0.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $354.3K | 4,452 | 0.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $357.7K | 4,994 | 0.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $359.0K | 3,892 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $364.0K | 11,625 | 0.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $365.0K | 80,743 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $366.7K | 9,084 | 0.2% |
| Cion Invt Corp(CION) | COM | 17259U204 | $367.9K | 32,533 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $371.8K | 26,201 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $374.2K | 6,251 | 0.2% |